Previous 10 | Next 10 |
Gainers: ProQR Therapeutics (NASDAQ:PRQR) +22%, Centessa Pharmaceuticals CNTA +22%, Kiromic BioPharma (NASDAQ:KRBP) +19%, Trinity Biotech TRIB +16%, Enveric Biosciences (NASDAQ:ENVB) +14%. Losers: Humanigen HGEN -54%, Invacare IVC -34%,...
DUBLIN, Ireland, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2021. Quarter 2 Results ...
ASO, OTCPK:DLMAF, HOV, LOVE, TRIB For Seeking Alpha's full earnings season calendar, click here. For further details see: Notable earnings before Thursday's open
DUBLIN, Ireland, Aug. 31, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter fiscal year 2021 on Thursday, Septem...
Gainers: China SXT Pharmaceuticals (SXTC) +37%, Trinity Biotech (TRIB) +11%, Moderna (MRNA) +9%, Aptevo Therapeutics (APVO) +9%, Apollo Medical (AMEH) +4%.Losers: FibroGen (FGEN) -45%, Neptune Wellness Solutions (NEPT) -20%, Atossa Therapeutic...
Trinity Biotech (TRIB) pops 8% premarket after providing a business development update for Q2 2021. In June 2021, the Company received an update from the WHO on the approval process of TrinScreen HIV. The WHO confirmed that their screening of the submission dossier is comp...
DUBLIN, Ireland, July 16, 2021 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) provides a business development update for Q2 2021. HIV Testing (TrinScreen™ HIV) Trinity Biotech has been the main confirmatory test provider for the detection of the HIV virus on the...
Trinity Biotech plc (TRIB) Q1 2021 Results Conference Call May 25, 2021 11:00 AM ET Company Participants Joe Diaz - Lytham Partners Ronan O’Caoimh - CEO John Gillard - CFO Conference Call Participants Paul Nouri - Noble Equity Funds Jim Sidoti - Sidoti & Co Presentation Operator Go...
Gainers: Flanigan's Enterprises (BDL) +73%.Pieris Pharmaceuticals (PIRS) +48%.RYB Education (RYB) +27%.uCloudlink (UCL) +24%.Friedman Industries (FRD) +23%.Taiwan Liposome (TLC) +19%.Provention Bio (PRVB) +19%.The Joint (JYNT) +18%.New Oriental Education & Technology (EDU) +18%....
Trinity Biotech ([[TRIB]] -6.2%) reports Q1 revenue of $25.6M (+20.9% Y/Y), beating expectations by $1.6M.Clinical laboratory revenues increased to $23.7M, which represents an increase of 32.9% compared to Q1, 2020; the rise in revenue was primarily due to strong sale...
News, Short Squeeze, Breakout and More Instantly...
DUBLIN, June 24, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced steps to advance its next generation continuous glucose monitoring (...
DUBLIN, June 10, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, announces that its senior management team plans to at...
DUBLIN, June 03, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the launch of its continuous glucose monitoring (“CGM”...